Hutchmed, a pharmaceutical company, is in the final stages of preparing a submis...
In a surprising turn of events, Gilead Sciences’ hopes for its magrolimab therap...
Novo Holdings, a prominent global life science investor renowned for fostering g...
After a string of failures in the clinic, the Tecentriq/Cabometyx combination de...
In the most recent update regarding U.K. cellular therapy firm Celixir in July 2...
After learning about a novel method for treating overactive bladder, the FDA has...
Nevro’s high-frequency neurostimulation system, after being granted FDA approval...
Midstage results indicated that Galecto’s inhalation treatment for idiopathic pu...
While dental technology has advanced significantly over the years, the ability t...
In a recent development, the US Food and Drug Administration (FDA) has placed an...
The FDA’s decision on Valneva’s chikungunya virus vaccine candidate, VLA1553, ha...
In recent months, Getinge’s intra-aortic balloon pumps have encountered several ...
Hims & Hers, a company specializing in online health and wellness products, anno...
Merck has solidified a substantial collaboration valued at $490 million with Gin...
Novartis is effectively navigating the competition to retain its foothold in the...
The FDA has officially granted approval to Iveric Bio’s intravitreal avacincapta...
